Enduring Material

Fatigue and the Impact of Musculoskeletal Pain on Quality of Life in Pediatric Patients With Psoriasis
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

1800 Diagonal Road, Suite 360
Alexandria, VA 22314
General Information
Tuesday, July 1, 2025 - Wednesday, July 1, 2026
30 minutes
National Psoriasis Foundation
Virtual Conference Room
Journal of Psoriasis and Psoriatic Arthritis
National Psoriasis Foundation
Objectives
  • Describe Systemic Impacts of Psoriasis in Pediatric Patients
  • Identify Early Indicators of Psoriatic Arthritis in Pediatric Populations
  • Optimize Patient-Centered Care for Pediatric Psoriasis
Presentations and Speakers
Fatigue and the Impact of Musculoskeletal Pain on Quality of Life in Pediatric Patients With Psoriasis
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Bruce Strober, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
AbbVie, Almirall, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Immunic Therapeutics, Bristol Myers Squibb, Connect Biopharma, Dermavant, Eli Lilly, Equillium, GlaxoSmithKline, Janssen, LEO Pharma, Maruho, Meiji Seika Pharma, Mindera, Novar - Consulting - Relationship Has Not Ended
AbbVie, Eli Lilly, Janssen, and Sanofi-Genzyme - Speaking - Relationship Has Not Ended
CorEvitas Psoriasis Registry - co-scientific director - Relationship Has Not Ended
AbbVie, Cara Therapeutics, the CorEvitas Psoriasis Registry, Dermavant, Dermira, and Novartis - investigator - Relationship Has Not Ended
Journal of Psoriasis and Psoriatic Arthritis - editor-in-chief - Relationship Has Not Ended

Sam Koons, NPF Staff, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
BMS - Consulting - Relationship Has Ended
This activity is not commercially supported.
Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
0 %
5/27/2025
Continue to Enduring Material